Key Financial Data Of Group

COSMOS Pharmaceutical Corporation - Filing #7569860

Concept As at
2023-02-28
2022-12-01 to
2023-02-28
2022-06-01 to
2023-02-28
2021-06-01 to
2022-05-31
As at
2022-05-31
2021-12-01 to
2022-02-28
2021-06-01 to
2022-02-28
As at
2022-02-28
Key financial data of group
Business results of group
Net sales
606,302,000,000 JPY
755,414,000,000 JPY
558,885,000,000 JPY
Ordinary profit (loss)
24,393,000,000 JPY
32,861,000,000 JPY
24,100,000,000 JPY
Profit (loss) attributable to owners of parent
16,283,000,000 JPY
23,155,000,000 JPY
16,455,000,000 JPY
Comprehensive income
16,291,000,000 JPY
23,198,000,000 JPY
16,466,000,000 JPY
Net assets
203,530,000,000 JPY
190,507,000,000 JPY
183,775,000,000 JPY
Total assets
376,930,000,000 JPY
363,052,000,000 JPY
343,433,000,000 JPY
Basic earnings (loss) per share
125.88
411.22
584.76
131.57
415.56
Diluted earnings per share
Equity-to-asset ratio
0.540 xbrli:pure
0.525 xbrli:pure
0.535 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.